Funding news
Signos logo

Signos Raises $20.0M

Recently funded · $20.0M Series bHospitals and Health CareView source

Get the full Signos company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Signos, a metabolic health platform focused on helping employees improve their well-being and providing employers with data for informed benefits decisions, has secured $20.0M in Series B funding. The capital will further its work in offering a proactive approach to workforce health, potentially reducing reliance on costly GLP-1 medications.

The company stands out as the first FDA-cleared platform of its kind, leveraging Dexcom’s Stelo CGM and AI-driven guidance. This technology translates real-time glucose data into personalized, actionable recommendations, supporting sustainable weight management and overall better metabolic health for employees.

Other recently funded companies

View all

Biggest recent Healthcare rounds

Largest funding rounds in Healthcare on Signalbase right now.

#CompanyAmount
1
Kismet logo

Kismet

Australia

$42.0B
2
Johnson & Johnson logo

Johnson & Johnson

United States

$7.0B
3
Inari Medical logo

Inari Medical

United States

$4.9B
4
MultiPlan logo

MultiPlan

United States

$4.5B
5
BABYLON HEALTHCARE SERVICES LIMITED logo

BABYLON HEALTHCARE SERVICES LIMITED

United Kingdom

$4.2B

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
Garner Health logo

Garner Health

$45.0M
2
XCENA logo

XCENA

South Korea

$135.0M
3
Photonic Inc. logo

Photonic Inc.

Canada

$70.0M
4
Slamcore logo

Slamcore

United Kingdom

$13.0M
5
Anveshan logo

Anveshan

India

$12.7M